Citations 2
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial
Geva, Michal , Goldberg, Y. Paul, Leitner, Melanie , Cruz-Herranz, Andrés , Hand, Randal, Emek, Noga Gershoni, Tan, Andrew M. , Berry, James D. , Berry, James D , Shefner, Jeremy M. , Goldberg, Y. Paul, Chen, Kelly , Gershoni‐Emek, Noga, Paganoni, Sabrina , Macklin, Eric A. , Cudkowicz, Merit , Hayden, Michael R.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | December 17, 2025 | Volume: 27 | Issue: 3-4 | Pages: 432-444
Pridopidine for the Treatment of ALS–Improvements in the Subgroup of Definite, Probable, and Early (
Geva, Michal , Meltzer, May, Cohen, Yaël C. , Hand, Randal, Leitner, Melanie , Shefner, Jeremy M. , Oskarsson, Björn , Lichtenstein, Rachel G. , Meltzer, May, Chen, Kelly , Paganoni, Sabrina , Cudkowicz, Merit , Hayden, Michael R.
Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available